The use of Noninvasive Indices of Hepatic Fibrosis to Detect Clinically Significant Portal Hypertension

被引：0
|
作者：
Regalia, Kirsten
Fortune, Brett E.
Smolkin, Maximiliano J.
Czwornog, Jennifer
Austin, Gregory
Everson, Gregory T.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S948 / S948
页数：1
相关论文
共 50 条
  • [41] Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension
    Zizalova, Katerina
    Novakova, Barbora
    Vecka, Marek
    Petrtyl, Jaromir
    Lanska, Vera
    Pelinkova, Kveta
    Smid, Vaclav
    Bruha, Radan
    Vitek, Libor
    Lenicek, Martin
    LIVER INTERNATIONAL, 2023, 43 (04) : 888 - 895
  • [42] Clinically significant portal hypertension in chronic liver disease: Always cirrhosis?
    Rodrigues, S.
    Berzigotti, A.
    Montani, M.
    De Gottardi, A.
    Bosch, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S734 - S734
  • [43] Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
    Azoulay, Daniel
    Ramos, Emilio
    Casellas-Robert, Margarida
    Salloum, Chady
    Llado, Laura
    Nadler, Roy
    Busquets, Juli
    Caula-Freixa, Celia
    Mils, Kristel
    Lopez-Ben, Santiago
    Figueras, Joan
    Lim, Chetana
    JHEP REPORTS, 2021, 3 (01)
  • [44] Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model
    Rabiee, Anahita
    Deng, Yanhong
    Ciarleglio, Maria
    Chan, Jean L.
    Pons, Monica
    Genesca, Joan
    Garcia-Tsao, Guadalupe
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (12) : 3324 - 3334
  • [45] BASELINE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND HCV INFECTION PREDICT THE DEVELOPMENT OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH)
    Garcia-Tsao, Guadalupe
    Groszmann, Roberto J.
    Bosch, Jaime
    Grace, Norman D.
    Burroughs, Andrew K.
    Planas, Ramon
    Escarsell, Angels
    Garcia-Pagan, Juon Carlos
    Makuch, Robert
    Patch, David W.
    Matloff, Daniel S.
    HEPATOLOGY, 2008, 48 (04) : 625A - 626A
  • [46] Effects of octreotide on hepatic fibrosis and portal hypertension in rat.
    Fort, J
    Oberti, F
    Pilette, C
    Veal, N
    Gallois, Y
    Douay, O
    Cales, P
    HEPATOLOGY, 1996, 24 (04) : 773 - 773
  • [47] PORTAL-HYPERTENSION IN A NEONATE WITH CONGENITAL HEPATIC-FIBROSIS
    GHISHAN, FK
    NAU, S
    YOUNOSZAL, MK
    SOUTHERN MEDICAL JOURNAL, 1981, 74 (02) : 243 - 244
  • [48] Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
    Jiegen Chen
    Josepmaria Argemi
    Gemma Odena
    Ming-Jiang Xu
    Yan Cai
    Veronica Massey
    Austin Parrish
    Rajanikanth Vadigepalli
    Jose Altamirano
    Joaquin Cabezas
    Pere Gines
    Juan Caballeria
    Natasha Snider
    Pau Sancho-Bru
    Shizuo Akira
    Ivan Rusyn
    Bin Gao
    Ramon Bataller
    Scientific Reports, 10
  • [49] Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
    Chen, Jiegen
    Argemi, Josepmaria
    Odena, Gemma
    Xu, Ming-Jiang
    Cai, Yan
    Massey, Veronica
    Parrish, Austin
    Vadigepalli, Rajanikanth
    Altamirano, Jose
    Cabezas, Joaquin
    Gines, Pere
    Caballeria, Juan
    Snider, Natasha
    Sancho-Bru, Pau
    Akira, Shizuo
    Rusyn, Ivan
    Gao, Bin
    Bataller, Ramon
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [50] Splenic Stiffness Is the Best Predictor of Clinically Significant Varices in Children With Portal Hypertension
    Upadhyay, Piyush
    Khanna, Rajeev
    Sood, Vikrant
    Lal, Bikrant Bihari
    Patidar, Yashwant
    Alam, Seema
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (03): : 364 - 370
12345